Two more firms contact Drap for vaccine registration

Published January 22, 2021
Two more companies have contacted the Drug Regulatory Authority of Pakistan (Drap) for registration and phase-III clinical trial of their Covid-19 vaccines. — AFP/File
Two more companies have contacted the Drug Regulatory Authority of Pakistan (Drap) for registration and phase-III clinical trial of their Covid-19 vaccines. — AFP/File

ISLAMABAD: While three foreign pharmaceutical companies have already developed their stakes in Pakistan, two more companies have contacted the Drug Regulatory Authority of Pakistan (Drap) for registration and phase-III clinical trial of their Covid-19 vaccines.

On Thursday, 2,363 new cases and 54 deaths were reported due to coronavirus in a single day as the number of active cases reached 35,293 across the country.

An official of the Ministry of National Health Services (NHS) said that Russia’s state-owned Sputnik-V company has filed an application seeking permission for emergency use of its vaccine in Pakistan.

“It is a double-dose vaccine and will be administered by syringes,” he said.

“Moreover, Chinese firm Anhui Zheifi Longcom Biopharmaceuticals Company Limited has applied for phase-III clinical trial of its vaccine in Pakistan. The vaccine has been jointly developed by the company and the Institute of Microbiology under the Chinese Academy of Sciences,” the official said.

Earlier, three firms had developed their interests in Pakistan as British firm Oxford-AstraZeneca and Chinese firm Sinopharm’s vaccines were registered with Drap. The third firm namely CanSino Biologics is also a Chinese firm and it has been conducting phase-III clinical trial of its vaccine in Pakistan.

54 die of Covid-19 in a single day in Pakistan

“Oxford-AstraZeneca’s vaccine will be received through the international alliance Covax and also through a private channel. Pakistan has pre-booked 1.1 million doses of Sinopharm’s vaccine,” the official said.

Meanwhile, Usman Ghani, a representative of Sindh Medical Store which has got Oxford-AstraZeneca vaccine registered with Drap, said the manufacturer had not given any timeline for supplying the vaccine because of priorities set by the Indian government for local preferences.

According to data of the National Command and Operation Centre, as many as 2,363 people were infected with coronavirus and 54 died due to Covid-19 in a single day. While there were 324 ventilators in use of Covid-19 patients, Multan’s 49 per cent, Islamabad’s 40pc, Lahore’s 37pc and Peshawar’s 30pc vents were in use.

Published in Dawn, January 22nd, 2021

Opinion

Editorial

Military option
Updated 21 Nov, 2024

Military option

While restoring peace is essential, addressing Balochistan’s socioeconomic deprivation is equally important.
HIV/AIDS disaster
21 Nov, 2024

HIV/AIDS disaster

A TORTUROUS sense of déjà vu is attached to the latest health fiasco at Multan’s Nishtar Hospital. The largest...
Dubious pardon
21 Nov, 2024

Dubious pardon

IT is disturbing how a crime as grave as custodial death has culminated in an out-of-court ‘settlement’. The...
Islamabad protest
Updated 20 Nov, 2024

Islamabad protest

As Nov 24 draws nearer, both the PTI and the Islamabad administration must remain wary and keep within the limits of reason and the law.
PIA uncertainty
20 Nov, 2024

PIA uncertainty

THE failed attempt to privatise the national flag carrier late last month has led to a fierce debate around the...
T20 disappointment
20 Nov, 2024

T20 disappointment

AFTER experiencing the historic high of the One-day International series triumph against Australia, Pakistan came...